Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To investigate the impact of insulin glargine versus Neutral Protamine Hagedorn basal insulin
on a composite diabetes related quality of life score (DRQoL).
Secondary Objective:
A comparison of combination therapy with insulin glargine versus Neutral Protamine Hagedorn
basal insulin from baseline to endpoint in terms of:
- Glycaemic parameters: 7 blood glucose profiles
- Incidence of confirmed symptomatic hypoglycemia as well as confirmed severe hypoglycemia
- Change in lipid status